Clinical Trials Browser

Phase 2 × Malignant Hepatobiliary Neoplasm × ponatinib × Clear all

NCT02265341 2020-11-25

Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions

Phase 2 Completed

12 enrolled 11 charts

Gastrointestinal

Malignant Hepatobiliary Neoplasm